In the present study we evaluated the effectiveness of 5ml nebulized normal saline (NS), 5ml nebulized L-adrenaline (1:1000) plus O,bg/Kgr dexamethasone (AD), and 5ml nebulized L-adrenaline plus 2ml nebulized budesonide (0,5mg/ml) (AB) i n 36 infants and children with croup. Their condition was characterized as mild, moderate o r severe, according t o a score based on stridor, cough, intercostal retractions, cyanosis and SaO saturation. A l l the children were i n i t i a l l y given NS. 'Iwentj three of them with similar croup scores vfio didn' t show any improvement 15' minutes a f t e r NS, were subsequently divided into two random groups: The f i r s t group received AD and the second was treated with AB. The croup score was evaluated a t 5' , 15; 30' , 60' , 120' and 180' minutes l a t e r . Two patients from group A B were excluded from the analysis. Our r e s u l t s showed that: a ) 85% (11/13) of patients who received AD and 100% (8/8) of the ones who received AB, had a s i i f i c a n t improvement 30' minutes a f t e r treatment and b) 77% r 0 / 1 3 ) of the AD group and 62,5% (5/8) of the A B group remained symptoms free, three hours l a t e r . In conclusionlit seems that there i s no difference between the two treatment regimes AD or AB, though more patients a r e needed t o confirm t h i s finding. The long-term effects of long-acting beta-2-agonists on the airway sensitivity. and maximal bronchoconstriction in asthmatic children have not been/ evaluated. We compared the effect of salmeterol 50 pg and saibutamoi 2001 pg bid. in 30 mild asthmatic children in a double-blind parallel study. None of/ the children were on inhaled corticosteroids. Methacholine dose-response1 curves were made up to a fall in FEV, of 45% or a maximal plateau bronchoconstriction was reached, before and during 4 months of treatment. PD, was always measured 12h after the last medication gift. PD, improved, significantly only during salmeterol treatment: 0.7 doubling dose in the! salmeterol group, -0.5 doubling dose in the saibutamol group (p<0.001). Maximal plateau bronchoconstriction was rarely seen, either before or during ,treatment. We conclude that salmeterol during long-term treatment improves airway sensitivity, but we could not demonstrate a maximal response plateau.
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POOR PROGNOSIS AFTER PROLONGED VENTILATION FOR BRONCHOPULKONARY DYSPLASIA. Mary Wheater, J a n e t M Rennie. NICU. Rosie Wdx.rnity Hospital, Robinson Way, Cabridge, K .
:
We have investigated m r t a l i t y and neurcdevelopnental rrorbldity among children ventilated for m r e than 28 days i n the y a -s between 1985 and 1992. There were 48 cases: 30 were m l e . ;5 were <1500g birthheight, and the VLBW group represented 5% of ILBWI admitted during this time.
Using regression analysis, days of ventilation proved a m r e powerful predictor of handicap than brain injury. The poor outlcok for n o m l survival a f t e r 40 days m y prove useful i n f o m c i o n t o clinicians faced with d i f f i c u l t decisions during a deterioration i n the condition of such babies. Relationships between asthma, disturbed sleep, and daytime cognition and behaviour were explored. Stage one: children, aged 616, with nocturnal asthma (NA) (n= lo), daytime asthma (DA) (n=10) and healthy controls (HC) (n=10) were compared on the following; sleep quality, daytime sleepiness and behaviour and cognition. Stage two: for NA, home polysomnography on the night before the arsessments. Two further sleep recordings and assessments at two and four weeks post successful treatment change. Results: preliminary results suggest: 1. NA show focal attention, memory and creativity deficits. Higher anxiety and inattention is reported. 2. DA also display focal attention deficits. 3. NA have poor subjective sleep quality and more daytime sleepiness. 4. polysomnography confirms that NA have repeated night waking, the frequency (mean 19.4 (sd 13.1)) per night and duration (mean 34.1 minutes (sd 33.0)) of which diminish after a successful ueatment change (mean 2.6 (d 3.0) and mean 3.0 (sd 4.3) respectively). Slow wave sleep and subjective sleep quality increase. 5. reported anxiety lessens. 6. recall improves. Divergent thinking remains lower than for the control groups. Focal attention, poor in comparison to HC is now comparable to DA. The focal attention deficit in both groups of children with asthma is being investigated. Conclusion: initial results suggest sleep disturbance experienced by NA has effects on daytime learning and behaviour, some of which can be r e v e r e by management of the nocturnal symptoms. The lung function tests (body plethysmography, flow-volume curve parameters, difusslon capacity, static and dynamic lung ampliance) were pereformed in 39 short stature children (12 boys, 17 girls aged 7-17, mean height 126+16 cm) . Examined group consisted of 18 children with growth hormone deficiency (GHD) and 21 control children with idiopathic short stature (ISS). The mean vaules of all examined parameters expressed in absolute values, or a s % of predicted (according to height) and a s "standardised residuals" were similar in both examined subgroups of children. Only In 3 GHD and in 3 ISS children t h e disturbances in airway resistance were observed and in 2 GHD and 2 ISS children the diminished diffusion capacity and static lung ampliance were found. We conclude that GHD had no Influence on lung function. Clinical studies demonstrated that allergens in the AM group included citrus fruits/drinks, cheeses ( s o l i d ) , chocolate and caffeine containing drinks.
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